Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts By Maggie Fick and Stine JacobsenOctober 17, 2025 at 11:03 PM 0 FILE PHOTO: A view shows a Novo Nordisk sign outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.
- - Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts
By Maggie Fick and Stine JacobsenOctober 17, 2025 at 11:03 PM
0
FILE PHOTO: A view shows a Novo Nordisk sign outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025. REUTERS/Tom Little/File Photo
By Maggie Fick and Stine Jacobsen
LONDON/COPENHAGEN (Reuters) -Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, as the obesity drugmaker faces growing pressure from U.S. President Donald Trump on drug pricing.
Miley, an American, is currently senior vice president of government affairs at U.S. pharmaceutical giant AbbVie. He posted a statement on LinkedIn on Friday and Novo Nordisk shared the statement with Reuters.
Novo's new CEO Mike Doustdar is trying to revive investor confidence through a major restructuring aimed at sharpening Novo's focus in a fierce obesity drug battle against U.S. rival Eli Lilly.
The overhaul includes cutting 9,000 jobs, with 5,000 positions being eliminated in Denmark and layoffs underway across multiple U.S. departments.
AbbVie did not immediately reply to a request for comment. Novo Nordisk sent Reuters Miley's statement on LinkedIn when asked for a comment. Miley did not immediately reply when contacted by Reuters earlier on Friday.
(Reporting by Maggie Fick in London and Stine Jacobsen in Copenhagen, Editing by Louise Heavens)
Source: "AOL Money"
Source: Astro Blog
Full Article on Source: Astro Blog
#LALifestyle #USCelebrities